Degarelix monotherapy versus luteinizing hormone-releasing hormone (LHRH) agonists plus antiandrogen flare protection in the treatment of men with advanced prostate cancer.

Bertrand Tombal; Jan-Erik Damber; Anders Malmberg; Bo-Eric Persson; Laurence Klotz; Peter Iversen

Degarelix monotherapy versus luteinizing hormone-releasing hormone (LHRH) agonists plus antiandrogen flare protection in the treatment of men with advanced prostate cancer.

Bidragets oversatte titel: Degarelix monotherapy versus luteinizing hormone-releasing hormone (LHRH) agonists plus antiandrogen flare protection in the treatment of men with advanced prostate cancer.

Bertrand Tombal, Jan-Erik Damber, Anders Malmberg, Bo-Eric Persson, Laurence Klotz, Peter Iversen

Bidragets oversatte titel	Degarelix monotherapy versus luteinizing hormone-releasing hormone (LHRH) agonists plus antiandrogen flare protection in the treatment of men with advanced prostate cancer.
Originalsprog	Engelsk
Tidsskrift	Journal of Clinical Oncology
Vol/bind	32
Udgave nummer	4_suppl
Sider (fra-til)	86
Antal sider	1
ISSN	0732-183X
Status	Udgivet - 2014

Adgang til dokumentet

http://meeting.ascopubs.org/cgi/content/abstract/32/4_suppl/86

Citationsformater

Tombal, B., Damber, J-E., Malmberg, A., Persson, B-E., Klotz, L., & Iversen, P. (2014). Degarelix monotherapy versus luteinizing hormone-releasing hormone (LHRH) agonists plus antiandrogen flare protection in the treatment of men with advanced prostate cancer. Journal of Clinical Oncology, 32(4_suppl), 86. http://meeting.ascopubs.org/cgi/content/abstract/32/4_suppl/86

Degarelix monotherapy versus luteinizing hormone-releasing hormone (LHRH) agonists plus antiandrogen flare protection in the treatment of men with advanced prostate cancer. / Tombal, Bertrand; Damber, Jan-Erik; Malmberg, Anders et al.

I: Journal of Clinical Oncology, Bind 32, Nr. 4_suppl, 2014, s. 86.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

Tombal, B, Damber, J-E, Malmberg, A, Persson, B-E, Klotz, L & Iversen, P 2014, 'Degarelix monotherapy versus luteinizing hormone-releasing hormone (LHRH) agonists plus antiandrogen flare protection in the treatment of men with advanced prostate cancer.', Journal of Clinical Oncology, bind 32, nr. 4_suppl, s. 86. <http://meeting.ascopubs.org/cgi/content/abstract/32/4_suppl/86>

@article{a908c68b89524aa09f949e40ca13fff1,

title = "Degarelix monotherapy versus luteinizing hormone-releasing hormone (LHRH) agonists plus antiandrogen flare protection in the treatment of men with advanced prostate cancer.",

author = "Bertrand Tombal and Jan-Erik Damber and Anders Malmberg and Bo-Eric Persson and Laurence Klotz and Peter Iversen",

year = "2014",

language = "English",

volume = "32",

pages = "86",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "4_suppl",

}

TY - ABST

T1 - Degarelix monotherapy versus luteinizing hormone-releasing hormone (LHRH) agonists plus antiandrogen flare protection in the treatment of men with advanced prostate cancer.

AU - Tombal, Bertrand

AU - Damber, Jan-Erik

AU - Malmberg, Anders

AU - Persson, Bo-Eric

AU - Klotz, Laurence

AU - Iversen, Peter

PY - 2014

Y1 - 2014

M3 - Conference abstract in journal

VL - 32

SP - 86

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 4_suppl

ER -